Protean Presents on the Importance of Precision Medicine in Uncovering a Patient's True Diagnosis at AMP 22
Roy Khalife, So Hyeon Park, and Anthony Magliocco from Protean BioDiagnostics will be presenting a case study this year at AMP 22, on the topic of the importance of precision medicine in uncovering a patient’s true diagnosis.
This is a case study that highlights the power of Protean to catch a liver carcinoma misdiagnosis using pathology review, comprehensive in-house molecular testing, and virtual molecular tumor boards.
For further information, please contact:
Anthony Magliocco MD
CEO & President of Protean BioDiagnostics
Email: info@proteanbiodx.com
Phone: 1 (813) 817 2042
About Protean BioDiagnostics
Protean BioDiagnostics is revolutionizing modern healthcare with our Protean MAPS™ system, which integrates health screening, diagnostics, treatment guidance, and tele-medicine backed decision support.
We collaborate with physicians and health groups to support them in providing the best possible care for their patients, regardless of where they live.